Navigation Links
Clinical trial to test whether vaccine can effectively treat melanoma
Date:4/6/2010

CHICAGO Rush University Medical Center is leading a nationwide Phase III clinical trial to determine whether a promising vaccine for advanced melanoma can effectively treat the deadly skin cancer.

An earlier Phase II trial of the experimental drug involving 50 patients with metastatic melanoma had stunning results. Eight patients recovered completely and four partially responded to the vaccine.

"Very few treatment options exist for patients with advanced melanoma, none of them satisfactory, which is why oncologists are so excited about the results we found in our Phase II study," said Dr. Howard Kaufman, associate dean of Rush Medical College and director of the Rush Cancer Program. Kaufman is leading the Phase III study.

Melanoma is a rare but deadly disease whose incidence is rising. According to the National Cancer Institute, there were 68,700 new cases of melanoma in 2009, and more than 8,500 deaths. The cancer typically begins in a mole, but can also lodge in other pigmented tissues, such as in the eye or in the intestines. If caught early, when the disease is superficial, the lesions can easily be removed surgically. But if it advances, the prognosis is poor. Median survival is six months to two years.

The vaccine being tested is called OncoVEX, initially developed to combat herpes virus. Researchers discovered accidentally that the vaccine attacked cancerous tissue when it was inadvertently placed in a Petri dish of tumor cells. The vaccine includes an oncolytic virus, a reprogrammed virus that has been converted into a cancer-fighting agent that attacks tumor cells while leaving healthy cells undamaged. OncoVEX also carries biological agents that boost the immune response to melanoma.

The vaccine is injected directly into lesions that can be felt or seen, with or without ultrasound. The procedure is generally done in a physician's office.

The earlier Phase II trial, an initial test o
'/>"/>

Contact: Sharon Butler
Sharon_Butler@rush.edu
312-942-7816
Rush University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. The CPM Resource Center launches Web-based clinical practice guidelines
2. Clinical benefit of multiple sclerosis drug discovered at Rush University Medical Center
3. Childrens Hospital Bostons Pain Treatment Service is named Clinical Center of Excellence
4. Almac to Improve Label Approval Process in Clinical Trials
5. Targeted agent blocked growth of deadly brain cancer in preclinical studies
6. New clinical prediction index to help patients considering kidney transplant
7. Kineta Awarded NIH Grant to Complete Preclinical Studies on Type 1 Diabetes / Multiple Sclerosis Drug Candidate
8. Childhood cancer patients enrolled in clinical trials need clearer communication about their role
9. Medical schools partner to tackle barriers to minority participation in cancer clinical trials
10. Carefx to Provide Clinical Workflow Solutions for Military Health System
11. The Indiana Clinical and Translational Science Institute (CTSI) Licenses GeneGos Eureka and MetaCore Platforms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... (PRWEB) May 05, 2015 Private equity ... FZ LLC has announced that its dental stem cell ... Store-A-Tooth™ increased once again--in April, 2015 –and posted yet ... of increased record volume and represents a significant 54% ... dental stem cell biobank is conducted via the Store-A-Tooth ...
(Date:5/5/2015)... “Given that Hispanics are one in six people ... are a major step in the arsenal of facts documenting ... past 30 years, data have accumulated that the health of ... the urgency and the need to create new models of ... all,” said Jane L. Delgado, PhD, MS, President and CEO ...
(Date:5/5/2015)... May 05, 2015 The global lab ... 2020 from $3,474.2 Million in 2014, at an estimated ... segments the lab automation market on the basis of ... and region. On the basis of application, Lab Automation ... solutions, and proteomics solutions. Drug discovery is a major ...
(Date:5/5/2015)... The newly minted Regan Arts has just released a unique self-help ... from his 20 years working in the field of wilderness therapy. ... a parenting book and why this one, she replied, “What resonates ... it is a journey, not a destination...that the question is not ... together and sometimes not...that each of our struggles is unique. What ...
(Date:5/5/2015)... Skedans Systems a division ... the Skedans Sensor Collaboration Platform at AUVSI's Unmanned ... app developers, provides tooling to deliver real time information ... The Skedans Sensor Collaboration Platform is a single unified ... of Things, Web Real Time Communications (WebRTC), and commercial ...
Breaking Medicine News(10 mins):Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 2Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 3Health News:“Its about time,” Declares the National Alliance for Hispanic Health on First CDC Study of Hispanic Health 2Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 2Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 3Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 4Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 5Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 2Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 3Health News:Skedans Systems Announces Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 in Atlanta 2
... patients with a devastating form of vasculitis who are in ... the disease flaring, according to a new study by investigators ... the first study to suggest that mental health is a ... disorders characterized by the inflammatory destruction of blood vessels. The ...
... Too few American doctors use oral food challenges to diagnose ... the gold standard, according to a new study. In ... if it causes an allergic reaction. This is done under ... identified 3,339 cases of food allergy. However, only 61.5 percent ...
... , SATURDAY, Nov. 5 (HealthDay News) -- Pregnancy ... study indicates. Lupus is a chronic inflammatory disease ... arthritis, fatigue and rashes. Lupus has been known to cause ... often emerging in their 20s and 30s when many women ...
... By Amanda Gardner HealthDay Reporter , FRIDAY, ... test may not be accurate in identifying a gene that ... get. The Oncotype DX, marketed by Genomic Health, results ... to a study published Oct. 18 in the Journal ...
... Households Financial strain and competing priorities at ... readmissions of children with asthma from single-parent homes compared ... at the American College of Allergy, Asthma and Immunology ... The study, performed at Cincinnati Children,s Hospital Medical Center, ...
... , FRIDAY, Nov. 4 (HealthDay News) -- Online forums ... with their feelings of loss and isolation, according to a ... System found the women are often driven to the Internet ... or family. They noted that half of the women who ...
Cached Medicine News:Health News:Stress triggers disease flares in patients with vasculitis 2Health News:Stress triggers disease flares in patients with vasculitis 3Health News:'Food Challenges' Provide Best Allergy Diagnoses: Study 2Health News:Pregnancy Safe for Most Women With Lupus: Study 2Health News:Common Breast Cancer Gene Test May Be Flawed, Study Says 2Health News:Common Breast Cancer Gene Test May Be Flawed, Study Says 3Health News:New interventions, recommendations for controlling allergies & asthma in children 2Health News:New interventions, recommendations for controlling allergies & asthma in children 3Health News:New interventions, recommendations for controlling allergies & asthma in children 4Health News:New interventions, recommendations for controlling allergies & asthma in children 5Health News:Online Forums Can Help Women Cope With Pregnancy Loss 2
(Date:5/5/2015)... QC , May 5, 2015 /CNW Telbec/ - ... Laval and known under the ... today the closing of the transaction previously announced on ... the issued and outstanding  shares of Orthoconcept (2008) inc.   ... issuing 500 000 common shares (TSXV: ERG) to the ...
(Date:5/5/2015)... EXTON, Pa. , May 5, 2015  The ... global leader in pharmacokinetic testing of drugs and safety ... Gum , Associate Director of Preclinical Studies, presented at ... in Vision and Ophthalmology (ARVO) in Denver, ... presentation was "Safety Assessment of a Novel, Cross-Linked, Bio-Absorbable ...
(Date:5/5/2015)... NIJMEGEN, the Netherlands , May ... company developing lower esophageal sphincter (LES) stimulation therapy ... positive safety and efficacy results. The results demonstrated ... heartburn and regurgitation and the "gold-standard" esophageal acid ... near-complete elimination of dependence on daily PPI medications. ...
Breaking Medicine Technology:Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 2Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 3Dr. Glen Gum of Absorption Systems Presents at The Association for Research in Vision and Ophthalmology (ARVO) Meeting 2Dr. Glen Gum of Absorption Systems Presents at The Association for Research in Vision and Ophthalmology (ARVO) Meeting 3Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 2Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 3
... (MARKET WIRE) -- July 06, ... <a target="_blank" href=,'http://studio.financialcontent.com/Engine?Account=iwire&PageName=QUOTE&Ticker=DORB"%3EDORB'>,http://studio.financialcontent.com/Engine?Account=iwire&PageName=QUOTE&Ticker=DORB">DORB ),("DOR" or ... the European Patent,Office has granted ... with claims related to,oral vaccination ...
... in The Lancet on TMC125, an Investigational ... /PRNewswire/ -- Data from two,ongoing Phase 3 ... adult patients with documented non-nucleoside reverse,transcriptase inhibitor ... undetectable viral load (defined as achieving,confirmed undetectable ...
Cached Medicine Technology:DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 2DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 3DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 4DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 5DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 6TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 2TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 3TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: